Regulators And Pharma Lock Horns On Pricing In India

India's drugs price regulator and the pharmaceutical industry appear to be at loggerheads again, after the government indicated that it could consider introducing an "enabling clause" in the existing regulation that would facilitate fixing the prices of around 300 products where market data is not available.